Status: Not yet recruiting
G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma
The goal of this phase 2 trial is to test the safety and efficacy of G-Pola-GemOx as induction therapy in patients with Refractory/Relapsed Aggressive B-Cell Lymphoma.
Participants needed: 80
Trial details
Phase: Phase 2Age: 14+Biological sex: AllType: InterventionalSponsor: Navy General Hospital, BeijingUpdated: Sep 22, 2025
Eligibility criteria
Pathologically confirmed Aggressive B-Cell Lymphoma (Including but not limited t... [+5]
Active or uncontrolled infections requiring systemic treatment within 14 days be... [+2]